The FDA will meet Feb. 26 to discuss what Johnson & Johnson says is a 66% effective, single-dose vaccine for preventing COVID-19.
Johnson & Johnson seeks FDA emergency authorization for COVID-19 vaccine - CNET
CNET - 5 Feb 2021 03:20
The FDA will meet Feb. 26 to discuss what Johnson & Johnson says is a 66% effective, single-dose vaccine for preventing COVID-19.
Share this Article
Comment on this Article
Recommended
Please to comment